Incorporating Esketamine into Practice for Treatment-Resistant Depression

EP: 1.Prevalence of Treatment-Resistant Depression

EP: 2.IV Ketamine for Treatment-Resistant Depression

EP: 3.Current Guidelines for Managing Treatment-Resistant Depression

EP: 4.Intranasal Esketamine for Treatment-Resistant Depression

EP: 5.Esketamine for Treatment-Resistant Depression: Patient Selection Criteria

EP: 6.Monitoring Patients on Esketamine Therapy for Treatment-Resistant Depression

EP: 7.Response to Esketamine Therapy for Treatment-Resistant Depression

EP: 8.REMS Safety Program for Esketamine in Treatment-Resistant Depression

EP: 9.Treatment-Resistant Depression: Administering Esketamine to Patients

EP: 10.Getting Certified to Administer Esketamine for Treatment-Resistant Depression

Now Viewing

EP: 11.Incorporating Esketamine into Practice for Treatment-Resistant Depression

EP: 12.Treatment-Resistant Depression: Financial Support for Esketamine Therapy

EP: 13.Frontline Psychotherapy for Depression

EP: 14.Traditional Classes of Antidepressant Therapies

EP: 15.Electroconvulsive Therapy for Depression

EP: 16.Integrated Care and Treatment-Resistant Depression

Requirements that healthcare clinics must satisfy to become a certified treatment center permitted to administer intranasal esketamine to patients with treatment-resistant depression.